CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond.
about
Human Tregs Made Antigen Specific by Gene Modification: The Power to Treat Autoimmunity and Antidrug Antibodies with PrecisionEngineered Tolerance: Tailoring Development, Function, and Antigen-Specificity of Regulatory T Cells.Rewiring T-cell responses to soluble factors with chimeric antigen receptors.Modeling Human Antitumor Responses In Vivo Using Umbilical Cord Blood-Engrafted Mice.Myeloid Conditioning with c-kit-Targeted CAR-T Cells Enables Donor Stem Cell Engraftment.
P2860
CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond.
@en
CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond.
@nl
type
label
CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond.
@en
CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond.
@nl
prefLabel
CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond.
@en
CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond.
@nl
P2860
P1476
CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond.
@en
P2093
Yvonne Y Chen
ZeNan L Chang
P2860
P304
P356
10.1016/J.MOLMED.2017.03.002
P577
2017-04-13T00:00:00Z